[ad_1] Medicare’s decades-old exclusion of weight-loss drug coverage is coming under scrutiny amid mounting evidence…
Obesity
-
-
STOCK MARKET
Novo Nordisk’s Wegovy cuts risk of heart attack and stroke by 20% among people without diabetes, study finds
by userby user[ad_1] Novo Nordisk’s popular weight-loss drug Wegovy significantly cut the risk of heart attack, stroke or…
-
STOCK MARKET
Amgen’s stock hit by expectations its obesity pipeline is facing a longer wait
by userby user[ad_1] Amgen Inc.’s stock fell 3.3% Tuesday to put it on track for its biggest…
-
STOCK MARKET
Johnson & Johnson beats earnings estimates and downplays obesity drugs’ impact on its med-tech business
by userby user[ad_1] Johnson & Johnson on Tuesday posted better-than-expected third-quarter earnings and raised its profit guidance…
-
STOCK MARKET
Novo Nordisk’s Wegovy reduces risk of adverse cardiovascular events by 20% in obese adults
by userby user[ad_1] Novo Nordisk’s U.S.-listed stock jumped rose 13% early Tuesday, after the company said its…
-
STOCK MARKET
As Ozempic/Wegovy frenzy continues, Morgan Stanley lifts forecasts for weight-loss drugs to $77 billion
by userby user[ad_1] Morgan Stanley on Friday lifted its forecast for annual sales of weight-loss drugs to…
-
[ad_1] Rite Aid Corp. said Thursday that its fiscal first-quarter pharmacy sales got a boost…
-
STOCK MARKET
5 fast facts about berberine, the weight-loss supplement blowing up on TikTok
by userby user[ad_1] By now, most Americans have heard of Ozempic, Mounjaro and Wegovy, the Type 2…
-
STOCK MARKET
Ozempic: Will Medicare cover this TikTok-trending weight loss and diabetes drug?
by userby user[ad_1] Ozempic, a medication used to treat Type 2 diabetes, has gone viral as a…
-
STOCK MARKET
These stock pickers led the health-fund category over the past 5 years. Here’s where they’re investing now.
by userby user[ad_1] The Baron Health Care Fund’s first five years have been exceptional in every sense…